To commemorate National Nurses Week 2025, Landy and Eric welcome our colleague Heather Smith, PhD, RN, NNP to the studio to discuss Mercalis’s burgeoning suite of nursing services that focus on patient care and education. Over the past several years, Mercalis nurses have played a vital role in the education of caregivers and patients, which has resulted in increased adherence and superior outcomes.

In this episode of Mercalis in Motion, Landy and Eric welcome to the studio two members of the Mercalis HCP Engagement Team: VP of HCP Engagement Operations Nolan Watts, and Business Development Manager John Katter. Please join us for an informative conversation that describes how Mercalis supports brands at any stage of the product life cycle by providing the following disciplines: •Contract Sales Teams •Field Reimbursement Support •Medical Science Liaisons •Clinical Nurse Educators •Institu...

Landy and Eric are joined in the studio by Mercalis President and Chief Commercial Officer Joe Abdalla and Mercalis Chief Strategy Officer and Head of Data & Insights Chris Apolito. In this episode, Joe and Chris reflect upon Mercalis's successful 2024 and look ahead to what's next for the life sciences commercialization partner in 2025 and beyond.

In this episode, Latrinda Williams, Mercalis's Senior Director of Employee Engagement and Culture joins Landy and Eric in studio to discuss her role within the growing Mercalis organization. Tune in to learn more about the lessons learned from COVID-19 and how Mercalis has maintained engagement and culture in a post-pandemic workplace. Latrinda also reflects on the importance of mental health and shares some best practices on ensuring inclusivity in fully remote or hybrid workforces.

In this episode, our hosts Landy Townsend, VP of Marketing and Communications, and Eric Manning, Creative Director, take a look back at our 2024 episodes, highlighting notable guests and discussions from the past twelve months. We hope you enjoy a recap of the people and topics that made an impact in 2024. Whether you are a Mercalis in Motion devotee or a first-time listener, we hope you'll join us for a look back at the year that was in life sciences.

Our Thanksgiving episode of Mercalis in Motion is now available! In this episode, Mercalis team members Michael Turner, Terry Cato, and Blake Johnson join us to discuss the impact the introduction of biosimilars has made on the pharmaceutical marketplace and how pharma manufacturers are developing strategy for biosimilar patient support services.

On this episode of Mercalis in Motion, Sean Boyler, Tom Gottschalk, and Robbie Hill join us in the studio to commemorate the 15-year anniversary of RxStudy Card. What follows is a conversation about how RxStudy Card by Mercalis has evolved over the years to save our clients millions of dollars in time and money while eliminating waste associated with the traditional clinical trial supply process.

Today, Landy and Eric welcome three members of the Mercalis Products Team to the studio. Bill Dupere, Stephanie Chesebro, and Nick Hill stopped by to discuss recent developments related to the Mercalis eServices and Curator capabilities. In November 2023, Mercalis announced an exclusive perpetual license to a portfolio of access and adherence technologies from OptimizeRx. Since then, the Products Team has been busy integrating and enhancing its catalog of market-leading patient su...

In this episode, Heather Smith, PhD, RN, NNP visits the studio to discuss the Mercalis Nurse Network. For the past seven years, Mercalis has provided its clients and their patients with a growing suite of services focused on patient care and education. The need for our Nurse Network was realized when we observed that parents and caregivers were being asked to mix medications and inject their children or family members. Since then, Mercalis nurses have served as an important ...

In this episode, Landy and Eric sit down with Jason Zemcik, Andrea Xu, and Bethany Najer of Policy Reporter by Mercalis to dive into a number of issues that are facing the life sciences market, as well as an update on Policy Reporter's offerings and what's on the horizon for the growing healthcare information management company . Tune in for a thought-provoking conversation about market dynamics and advancements in market access.

Today on Mercalis in Motion, we’re pleased to share an episode featuring our colleagues from Triangle Insights Group by Mercalis. Triangle Insights Group, acquired by Mercalis in April 2022, is a premier strategy consulting firm providing guidance on critical business issues to life science industry leaders. On this episode, Matt Haynes and Meghna Shankar discuss a recent white paper titled “The Indirect Impacts of the Inflation Reduction Act on Pharmaceutical Pipeline and Portfolio Str...

Rare Disease Day is an observance that takes place worldwide to raise awareness for rare diseases and improve access to treatment and medical representation for individuals with rare diseases and their families. Rare Disease Day typically takes place on or near the last day of February. In this episode of Mercalis in Motion, Landy and Eric welcome to the studio two guests from Catalyst Pharmaceuticals — Amy Grover, Senior Director of Patient Advocacy and Carrie Ostrea, Senior Mana...

Mercalis CEO Scott Dulitz joins Landy and Eric for Mercalis in Motion’s first podcast episode of 2024. Scott reflects on a very eventful and successful 2023 as well as what lies ahead for the life sciences commercialization partner in 2024 and beyond.

In this episode, our hosts Landy Townsend, Vice President of Marketing and Communications, and Eric Manning, Creative Director, take a look back at 2023, highlighting notable guests and key discussions from the past 12 months. No frills or fluff—just a recap of some of the people and topics that made an impact. Whether you're a regular listener or just tuning in, join us for a review of the conversations that shaped our year.

Copay accumulators have been a major topic of discussion in the life sciences community for the past several years, and Mercalis has been extremely busy providing continued guidance and support to our clients who have been impacted. After several recent legal developments, we decided to devote an episode of our Mercalis in Motion podcast to discuss the latest updates via a roundtable discussion. We welcomed to the studio our colleague Michael Harris, Mercalis’ VP of Patient Support Services S...

In this episode of Mercalis in Motion, we welcome to the studio Mercalis CEO Scott Dulitz to discuss TrialCard’s recent rebranding initiative that resulted in the creation of Mercalis. Scott discusses the reasons that led to the rebranding, how we arrived at the name Mercalis, and what’s next for the growing integrated life sciences commercialization partner.

Diana Villanova, TrialCard’s VP of Patient Support Services Strategy, joins Landy and Eric on today’s episode, to discuss Alternate Funding Programs (AFPs). Designed to limit plan sponsors’ financial exposure, the increased use of AFPs has introduced new access challenges for patients, plans, and manufacturers alike.

The Drug Provisions within the Inflation Reduction Act (IRA) of 2022 are of critical importance to pharmaceutical manufacturers, who now have a host of new considerations when thinking through their portfolio strategies and pricing and market access considerations. In this episode of TrialCard TALK, Landy and Eric welcome to the studio two experts on the topic: Megan Thomas, Partner, Triangle Insights Group and Jason Zemcik, Principal Consultant for Policy Reporter.

In this episode of TrialCard TALK, we welcome to the studio Chris Harris, TrialCard's Vice President of Operations, to discuss the growth and impact that TrialCard's non-commercial dispensing pharmacy has had on the organization and its clients.

In this episode of TrialCard TALK, Landy and Eric welcome to the studio Dean Erhardt, President & CEO of D2 Solutions. D2 is a healthcare solutions company that leverages consulting expertise with SaaS-based technology tools to drive revenue, enhance operational efficiency, and decrease exposure to regulatory risk for pharma and biotech manufacturers, specialty pharmacies, payers, and hospitals/IDNs. Mr. Erhardt has over 30 years of strategic marketing and management experienc...